Following four years of development, Withings, global leader in connected health is proud to announce U-Scan, a breakthrough in-home biomarker analysis platform.
One of the company’s most technologically advanced devices to date, U-Scan is a miniaturized health lab
that hygienically sits within any toilet bowl to unlock the wealth of health information in daily urine.
U-Scan has already been recognized by the Consumer Technology Association as a CES 2023 Innovation Award honoree in three categories: Smart Home, Fitness & Sports, and Digital Health.
With more than 3000 metabolites, urine is an extraordinary witness to assess and monitor one’s health. It gives an immediate snapshot of the body’s balance and is integral in monitoring and detecting a large variety of health information. While we urinate on average 7 times a day, urine analyses are usually performed only once a year.
Withings U-Scan aims to change that by making it possible in the future to conduct biomarker assessments from the comfort and privacy of a person’s own bathroom.
A game changer in home health, U-Scan is designed to be a versatile platform consisting of a technologically advanced pebble-shaped reader and changeable analysis cartridges designed to assess specific biomarkers without the need for external sample capture or strips.
Then, with seamless sync to the Withings Health Mate app, it will provide a wealth of actionable insights based on daily readings.
It will debut in Europe with two consumer health cartridges with medical versions following in the future. These include U-Scan Cycle Sync for women’s monthly cycle tracking and syncing and U-Scan Nutri Balance, a detailed metabolic guide to hydration and nutrition. Withings U-Scan is in development in the US and will not be available until it receives FDA clearance.
In addition, Withings Health Solutions, the company’s business to business division serving the healthcare provider market, is making the technology available to partners for research purposes.
“The ability of U-Scan to perform daily urine analysis from the home will allow Withings to take its mission to help consumers fully utilize urine data to an entirely new level,”
said Mathieu Letombe, Withings CEO.
“It’s one of the most exciting and complex products we have ever announced. We begin this journey with U-Scan Cycle Sync and Nutri Balance and look forward to announcing more cartridges on an ongoing basis as well as medical applications of the technology.”
